|
|
|
TACKLING CLINICAL TRIAL DATA OVERLOAD WITH DATA LAKES AND MACHINE LEARNING whitepaper Oct 31, 2019 Clinical trial data come from many different clinical (i.e. EDC, eCOA, lab, ePro, EMR/EHR, biomarker, mHealth / IoT), and operational (project management, eTMF, regulatory, financial, employee) sources and formats. Read More |
|
THE BENEFITS OF LOW ENDOTOXIN PRODUCTS whitepaper Oct 29, 2019 It is important to control the level of endotoxin units in materials used in the production of drug products and medical devices, especially those that cannot undergo depyrogenation. Read More |
|
PHARMA QUALITY CONTROL TESTING whitepaper Oct 09, 2019 Quality control (QC) plays a major role in the development of safe, highquality pharmaceutical products. This Pharmaceutical Technology/ Spectroscopy eBook on Pharma Quality Control Testing helps laboratories ensure they are up to date on the latest tools and techniques for achieving precise and eff... Read More |
|
|
DIGITAL THERAPEUTICS: PHARMA’S THREAT OR OPPORTUNITY whitepaper Sep 30, 2019 The DTx market is like the early days of the biologics revolution. “We are right at the beginning – it is a whole new therapeutic modality and we have the opportunity to create upwards of 100 products to increase efficacy across a range of disease conditions”. But does it represent... Read More |
|
|
MOVING MOLECULES INTO MEDICINES whitepaper Sep 13, 2019 The pharmaceutical R&D ecosystem relies on effective collaboration between internal and external stakeholders to collect, analyze, and share data in a secure, compliant, and efficient manner. Read More |
|
|
|
NEEDLE FREE INJECTION TECHNOLOGY- AN OVERVIEW whitepaper Aug 29, 2019 Injuries which occur on regular basis in day today routine of hospital and healthcare setups. The Plethora of new injectable products has created new opportunities for physicians to treat areas previously thought to be not reachable. Read More |
COST SAVINGS AND BUSINESS BENEFITS OF THE MADISON LOGIC PLATFORM whitepaper Aug 29, 2019 In account-based marketing (ABM) campaigns, B2B marketers can target contacts with pinpoint accuracy through programmatic advertising. They can also create personalized content for buyers at every stage of the purchase journey. However, three challenges remain: Are businesses targeting the right con... Read More |
OVERCOMING DRUG SHORTAGES WITH TECH whitepaper Aug 25, 2019 Medication shortages come with a substantial cost to pharmaceutical companies—loss of revenue, provider loyalty, and brand reputation pose significant and detrimental threats to business. Currently, the United States Food and Drug Administration (U.S. FDA) lists over 150 drug shortages, costin... Read More |
WHY AI? HOW LANGUAGE & AI SERVICES GO HAND-IN-HAND whitepaper Aug 21, 2019 In practice, of course, things are more complicated. Effective translation necessitates a nuanced understanding of (at least) two languages and cultures, both source and target. It requires an understanding of the original content’s goals. It mandates a fluency in tone and subtext as well as v... Read More |
A BUYER’S GUIDE FOR LOCALIZATION SERVICES: whitepaper Aug 21, 2019 Your localization partner is going to do a deep-dive into your business—so start by diving deep into theirs. Are they an industry-leader with 20 years of experience or a relative newcomer? Will they speak Samoan, Uzbek, or Swahili (and all your customers’ languages)? Can they deliver on-... Read More |
PATIENT MANAGEMENT PROGRAM (PMP) OVERVIEW whitepaper Aug 19, 2019 Benzer Pharmacy Specialty Pharmacy Patient Management Program proactively works with patients in a number of chronic disease states to provide specialty pharmaceuticals and therapy management support services to obtain optimal therapeutic outcomes thus avoiding adverse drug events and unnecessary co... Read More |
LAUNCHING GLOBAL CLINICAL TRIALS whitepaper Aug 19, 2019 This white paper highlights the language challenges found in a global clinical trial and offers a number of best practices for managing the translation effort. Failure to adequately plan for translation introduces several new risk factors that must be considered in today’s highly-competitive p... Read More |
USING CONTENT MARKETING TO GENERATE DEMAND, CREATE NEW AUDIENCES whitepaper Aug 14, 2019 Content—and how brands use it to interact with buyers at all stages of the engagement journey—has fundamentally reshaped every business’ go-to-market strategy. This shift has been particularly challenging for “top-of-the-funnel” demand generation marketers, most of who ... Read More |
COPAY ACCUMULATOR PROGRAMS & PHARMA: WHAT’S NEXT? whitepaper Aug 02, 2019 Dynamics between pharma and the market-based healthcare sector it serves have invariably been complex, with one of the biggest drivers of that complexity being effective management of patient demand and payer systems. Read More |
|
|
REAL-TIME TEMPERATURE MONITORING FOR PHARMA COLD CHAIN LOGISTICS whitepaper Jul 23, 2019 When it comes to safely and securely transporting high value pharmaceutical products, the stakes couldn’t be higher. Not only is a single consignment of high value drugs potentially worth upwards of $50 million, but, for those patients in need of these drugs, ensuring these products arrive on ... Read More |
|
IMPACT ON COMBINATION PRODUCTS AND COMPANION DIAGNOSTICS whitepaper Jul 19, 2019 With the end of the Medical Device Regulation’s (MDR) transition period looming (May 26th, 2020), manufacturers of drug device combination products or companion diagnostics are under heightened time pressure to comply with the new Regulation. Any company manufacturing or distributing these pro... Read More |
IOT TECHNOLOGIES & INFORMATICS INTEGRATION IN PHARMACEUTICALS whitepaper Jul 17, 2019 IoT technologies are proving to be of great benefit to pharmaceutical organizations that aim to innovate. The ability to integrate informatics solutions in pharmaceutical environments enables organizations to streamline and standardize connectivity from previously disparate equipment, networks, and ... Read More |
|
COMPETE AND WIN IN THE AGE OF ACCOUNT BASED BUYING whitepaper Jul 15, 2019 If you’re on a B2B revenue team, it’s likely your Marketing and Sales teams are experiencing some angst these days when it comes to understanding how prospects and customers want to interact with your company. On one hand customers seem to want ultra-personalized attention on every chann... Read More |
|
NUCLEAR RECEPTORS & ENDOCRINE / METABOLIC DISRUPTION whitepaper Jul 12, 2019 From our understanding today, there are many environmental chemicals that carry the potential to affect the endocrine system. Known as endocrine disrupting chemicals (EDCs), these compounds alter drug and xenobiotic metabolic processes and can interfere with the production, release, metabolism, and ... Read More |
HOW DOES PHARMA LEARN TO SPEAK “PATIENT”? whitepaper Jul 11, 2019 This eBook takes readers through an example of discourse analysis of a patient community on Inspire. In the process, author Kathryn Ticknor demonstrates how the language of patients is a different language from “medicalese,” the language of medicine. Her insights are a first ... Read More |
OXETANES IN DRUG DISCOVERY whitepaper Jul 10, 2019 Oxetanes have been employed to improve drugs’ physiochemical properties. Currently, over a dozen oxetane-containing drugs have progressed to different phases of clinical trials. Once one of them gains the FDA approval, the enthusiasm toward its utility in drug discovery will grow exponentially... Read More |
|
|
RUSSIA: SERIALIZATION AND AGGREGATION OF MEDICATIONS BECOMING MANDATORY. whitepaper Jul 10, 2019 Counterfeit products naturally pose a major problem in the pharmaceutical sector. This affects brand-name and generic products as well as OTC (over the counter) products. Counterfeiters not only bring imitation medication into circulation through non-authorized pharmacies and online portals, but als... Read More |
PHARMACOVIGILANCE AUTOMATION HAS ARRIVED whitepaper Jul 10, 2019 The rising cost of pharmacovigilance (PV) tasks has been an ongoing challenge for the pharma industry. Many companies have chosen to shift these tasks to overseas vendors to take advantage of cheaper labor without compromising quality. Read More |
|
IOT TECHNOLOGIES & INFORMATICS INTEGRATION IN PHARMACEUTICALS whitepaper Jul 09, 2019 IoT technologies are proving to be of great benefit to pharmaceutical organizations that aim to innovate. The ability to integrate informatics solutions in pharmaceutical environments enables organizations to streamline and standardize connectivity from previously disparate equipment, networks, and ... Read More |
THE SIRIUSDECISIONS B-TO-B BUYING DECISION PROCESS FRAMEWORK whitepaper Jul 08, 2019 Decisionmaking is a cognitive process defined by psychologists as the selection of a course of action from multiple alternatives (e.g. what to eat, where to shop). John Dewey, the pragmatic philosopher and psychologist, introduced the first decision process framework for consumer buying in his book ... Read More |
DIA & VIFOR PHARMA whitepaper Jul 08, 2019 Our latest white paper discusses the dynamics and marketing of 2018’s top selling drugs, chief therapeutic areas, and biosimilar erosion, with a deeper dive into the top three drugs: Humira, Revlimid, and Opdivo. Read More |
THE MEDICINE MAKER whitepaper Jun 29, 2019 The cannabis business is booming and pharma is looking to get in on the action with new business models and potential new drugs derived from the cannabis plant. Read More |
|
POSITIONING YOUR PHARMACEUTICAL LAB FOR SUCCESS whitepaper Jun 26, 2019 A pharma lab needs regulatory documentation, while a diagnostics lab requires advanced tracking of biospecimens. Traditionally, each would begin with the same basic building blocks: a Laboratory Information Management System (LIMS) with standalone point solutions such as an Electronic Laboratory Not... Read More |
|
A DECADE IN REVIEW: ONCOLOGY TRIAL BENCHMARKS AND SPONSOR ANALYSIS whitepaper Jun 25, 2019 The average cost of bringing a new drug to market continues to rise, with varying levels of investments across the highly competitive biopharmaceutical industry. To assess the potential effect of varying investments on trial activity and operations, this article reviews trial benchmarks within the a... Read More |
|
HOW TO OPTIMISE PHARMA’S DIGITAL HCP ENGAGEMENT whitepaper Jun 24, 2019 Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a company can offer and an HCP’s needs. Read More |
DIRECTIVE CONSULTING PORTFOLIO whitepaper Jun 24, 2019 We believe that data-driven marketing shouldn’t be confusing. Every company should know what works for their campaigns in order to make more ROI-driven decisions. At Directive, we not only craft customized campaigns for your unique marketing objectives - we exceed those objectives and truly re... Read More |
NEW INSIGHTS IN COMPUTATIONAL METHODS FOR PHARMACOVIGILANCE whitepaper Jun 24, 2019 Today’s surge of big data coming from multiple sources is raising the stakes that pharmacovigilance has to win, making evidence synthesis a more and more robust approach in the field. In this scenario, many scholars believe that new computational methods derived from data mining will effective... Read More |
COMPUTATIONAL INFRASTRUCTURE FOR MODERN PHARMACEUTICALS whitepaper Jun 19, 2019 This paper, authored by Alireza Shabani, Founder & CEO of Qulab, describes the necessary computational architecture for pharmaceutical firms to accelerate R&D and drug discovery, especially utilizing special purpose silicon and quantum processors. Read More |
WEIGHING IN PHARMACEUTICAL QUALITY CONTROL ACCORDING TO U.S. PHARMACOPEIA whitepaper Jun 19, 2019 USP Chapter 41 weighing requirements are mandatory in a Pharmaceutical Quality Control (QC) laboratory, where weighing is a fundamental step in almost every workflow. Typically, weighing of a sample or standard is the first step in the analytical procedure, followed by subsequent dilution and analys... Read More |
WEIGHING IN PHARMACEUTICAL QUALITY CONTROL ACCORDING TO US PHARMACOPEIA whitepaper Jun 19, 2019 This white paper fully explains the requirements of the 2019 versions of the USP General Chapters 41 and 1251 and provides guidance on how to put these requirements into practice. Weighing according to USP requirements ensures that consistently high quality weighing results are achieved and applies ... Read More |
|
FREE DRUG & ALCOHOL PROGRAM whitepaper Jun 11, 2019 The cost of employee substance abuse adds up quickly, and it is vital for your company to detect and deter drug and alcohol abuse among employees. Read More |
|
CUSTOM MANUFACTURING IN PHARMA whitepaper Jun 11, 2019 Contract development and manufacturing organisations (CDMOs) in the pharmaceutical world are on the up. They benefit from an increasing number of companies that outsource parts of their production to external service providers. Read More |
COMPETITIVE INTELLIGENCE IN AN AGILE WORLD whitepaper Jun 09, 2019 This thought piece explores the concept of agile working for the pharma world, delving into the opportunities and challenges that arise for CI teams and managers as working environments adapt to find success in a more dynamic, uncertain, and fast-paced environment. Read More |
CUBIS® II PHARMA COMPLIANT BY DESIGN whitepaper Jun 06, 2019 Sartorius Cubis® II is designed to follow US FDA data integrity principles that require data to be accurate, legible, contemporaneous, original and attributable. Read More |
X-RAY INSPECTION MORE THAN JUST CONTAMINATION DETECTION whitepaper Jun 03, 2019 This white paper looks at the potential of x-ray inspection to solve a wide range of product safety and quality control issues typically found within food and pharmaceutical manufacturing. It explores how x-ray inspection can detect faulty products before they leave the factory, avoiding product rec... Read More |
|
BETTER WAYS TO HANDLE TABLETS USING IBCS whitepaper May 30, 2019 It is common to find Intermediate Bulk Containers (IBCs) being used for handling powders and granules in solid dosage manufacturing processes, from initial Dispensing through to Tablet Compression or Capsule Filling. The benefits of using IBCs for efficient and flexible materials handling at this st... Read More |
|
BETTER BUILDINGS FOR BETTER PHARMACEUTICAL PRODUCTION whitepaper May 28, 2019 Embracing and investing in new technologies is one way to get ahead, and adopting lean, efficient manufacturing procedures is another. At a fundamental level, achieving efficiency can start at the outset of a project by considering the very design of a production facility. Careful planning can cut c... Read More |
BIOPHARMA MANUFACTURING TRENDS whitepaper May 27, 2019 The biopharma sector has seen incredible growth in recent decades, with growth the major long-term trend. Total annual revenue has increased from about $4.4 billion in 1990 to now about $275 billion, an increase of 6,250 percent, with biopharmaceuticals now more than 25 percent of the total pharmace... Read More |
|
|
|
|
|
STATE OF PHARMA MANUFACTURING 2019 whitepaper May 01, 2019 The past year was marked by shifting business models, more stringent quality requirements, technological improvements and mounting political pressures to solve pharma-related policy issues. How has the industry responded? Read More |
DEMAND FORECASTING IN PHARMACEUTICAL SUPPLY CHAINS: A CASE STUDY whitepaper Apr 30, 2019 Demand forecasting plays a critical role in logistics and supply chain management. In the paper, state-of-art methods and key challenges in demand forecasting for the pharmaceutical industry are discussed. An integrated procedure for in-market product demand forecasting and purchase order generation... Read More |
|
UNDERSTANDING DATA TRUST IN HEALTHCARE whitepaper Apr 29, 2019 For U.S. healthcare leaders, trusted data is more important than ever, as their organizations migrate from the fee-for-service model to value-based care. During this transition, healthcare organizations must weigh investments, risks, and trade-offs objectively with quantitative, trustworthy data. Read More |
|
SOLID DOSAGE AND EXCIPIENTS whitepaper Apr 24, 2019 For many reasons from ease of administration to dosing accuracy to manufacturing efficiency pharmaceutical manufacturers prefer to formulate their APIs as solid dosage drugs, and particularly tablets. There is significant room, however, for improvement of tableting processes. Advances in tableting t... Read More |
WHY DRUG MANUFACTURING NEEDS TO BECOME MORE FLEXIBLE whitepaper Apr 22, 2019 Digital transformation does not stop at the pharmaceutical industry. But until Pharma 4.0 can become socially acceptable, it will first and foremost be necessary to define globally uniform standards. This is going to take time. Time which the industry does not have in view of the speed of developmen... Read More |
PIPELINES AND PATIENTS DRIVE FINISHED DOSAGE OPPORTUNITIES whitepaper Apr 22, 2019 Efforts to ease patient burden with multi-API products and the increasing number of candidate products with low bioavailability are creating opportunities for contract manufacturing and development organizations (CDMOs) to create value with innovative, but complex, finished dosage formulations. Prov... Read More |
HOT MELT EXTRUSION FOR ORAL SOLID DOSAGE FORMS whitepaper Apr 18, 2019 Approximately half of all marketed drugs are administered orally, mostly in solid forms such as tablets or capsules. However, many APIs suffer from poor water solubility which leads to slow dissolution rates in the gastrointestinal tract and poor oral bioavailability. Hot melt extrusion is an effici... Read More |
|
PHARMA'S ROAD MAP TO PATIENT CENTRICITY whitepaper Apr 16, 2019 Over the past decade, the healthcare ecosystem has slowly moved toward the “triple aim”: better healthcare experiences, improved outcomes, and a slowing of the growth of overall healthcare costs. While many pharma companies have focused on educating and engaging patients to promote share... Read More |
APPLICATIONS IN PHARMACEUTICAL MANUFACTURING whitepaper Apr 16, 2019 The use of aqueous cleaning in pharmaceutical manufacturing can provide numerous benefi ts in terms of effectiveness, minimal surface residue, and easier cleaning validation. Virtually any pharmaceutical manufacturing equipment — from tablet presses to a stainless steel mixing tanks — ca... Read More |
|
UNDERSTAND MARKET ACCESS TRENDS IN THE US, EUROPE AND EMERGING MARKETS whitepaper Apr 10, 2019 Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets. With governments and private healthcare systems under increasing pressure to fund high-cost, innovative therapies, which often launch with limited clinical trial evid... Read More |
HORIZONS IN HIV DRUG DEVELOPMENT – WHAT’S PAST IS PROLOGUE whitepaper Apr 10, 2019 To better predict the future of HIV pharmaceuticals, we must understand the past – that’s the premise behind Horizons in HIV Drug Development – What’s Past is Prologue, the free whitepaper from Citeline, part of the Informa Pharma Intelligence suite of industry intelligence s... Read More |
|
|
PHARMA 2020: MARKETING THE FUTURE
WHICH PATH WILL YOU TAKE? whitepaper Apr 04, 2019 The social, demographic and economic context in which the pharmaceutical industry (Pharma) operates is changing dramatically, as we noted in “Pharma 2020: The vision”, the White Paper PricewaterhouseCoopers* published in June 2007 (see sidebar, Seven major trends reshaping the pharmaceut... Read More |
|
RISK MANAGEMENT PROGRAMS FOR THE
PHARMACEUTICAL INDUSTRY whitepaper Apr 02, 2019 The FDA’s cGMPs for the 21st Century: A Risk-Based Approach Initiative In early 2002, the Food and Drug Administration (FDA) announced their Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach initiative. According to the FDA position paper: “The FDA oversees the quality of ... Read More |
|
PHARMACEUTICAL PATENT TERM EXTENSION whitepaper Mar 27, 2019 A period of market exclusivity is critical for most novel pharmaceutical products and the duration of that exclusivity has a direct impact on the value of a pharmaceutical asset. There several forms of exclusivity that can apply to pharmaceutical products. This overview is a summary of one of them: ... Read More |
PHARMA R&D ANNUAL REVIEW 2019 SUPPLEMENT whitepaper Mar 21, 2019 Following on from our review of trends in the current pharmaceutical R&D pipeline, published in March 2019 this supplement takes a look at the industry’s success stories of 2018 – the drugs which were launched on to the market for the first time during the year. Our survey focuses ex... Read More |
GENOMIC ANALYSIS IN THE AGE OF HUMAN GENOME SEQUENCING whitepaper Mar 21, 2019 Affordable genome sequencing technologies promise to revolutionize the field of human genetics by enabling comprehensive studies that interrogate all classes of genome variation, genome-wide, across the entire allele frequency spectrum. Read More |
LEVERAGING PREDICTIVE ANALYTICS FOR PHARMACEUTICAL INNOVATION whitepaper Mar 20, 2019 Pharmaceutical companies aiming to develop innovative new therapies and treatments face many challenges. Without proper processes and systems in place, it is very difficult to replicate successful results, mitigate failures, reduce product variability and ultimately deliver a new therapy to market. ... Read More |
|
BIOPHARMA MANUFACTURING TRENDS 2019 whitepaper Mar 14, 2019 How slow-motion trends are driving biopharma growth, the dangerous impact of unproven stem cell therapies and more. For over two decades, the biopharmaceutical manufacturing industry has created a body of industrial knowledge and institutional experience. Read More |
|
BREAKING NEW GROUND IN DIGITAL CONTENT DELIVERY FOR PHARMA whitepaper Mar 12, 2019 It’s all too easy for pharmaceutical processes to slow marketing campaigns, rendering them unmanageable and ineffective, but a ground-breaking initiative is proving that digital content delivery can be timely, effective and drive a return-on-investment. Read More |
EXPLORING THE HALLMARKS OF CANCER WITH REAL-TIME LIVE-CELL ANALYSIS whitepaper Mar 11, 2019 Our understanding of tumor biology is constantly evolving and helps to shed new light on the behavior of many cancers as well as providing new pharmacological targets and treatment strategies. Over the past decade, there have been immense technological advances in the field of in vitro translational... Read More |
ACCELERATING ANTIBODY DEVELOPMENT WITH AUTOMATED OCTET ASSAYS whitepaper Mar 11, 2019 Drug development and production are challenging, however, high throughput characterization systems can greatly accelerate discovery programs. Using a proprietary discovery and development platform technology, Avitide enables its partners to rapidly advance candidate molecules to the clinic and achie... Read More |
|
IMPROVING T CELL FUNCTION IN THE SOLID TUMOR MICROENVIRONMENT whitepaper Mar 09, 2019 In recent years, cancer immunotherapies, in particular, immune checkpoint blockade and combination therapies, have demonstrated remarkable success in treating multiple refractory cancers. One such therapeutic approach prevents T cell exhaustion by blocking the PD-1/PD-L1 pathway, which has shown tum... Read More |
|
HEALTHCARE 2030 THE CONSUMER AT THE CENTER whitepaper Feb 26, 2019 The healthcare industry is facing major demographic changes that will dramatically impact which services are needed and how they are delivered. As Millennials, Generation X, and Baby Boomers enter new life stages at the same time, there are simultaneous demands for lower cost, convenient care ... Read More |
TRANSFORMATIONAL DRIVERS IN THE HEALTH SYSTEM OF THE FUTURE whitepaper Feb 20, 2019 While there are many perspectives and publications on the “Hospital of the Future,” few, if any, provide a system perspective. Too often, when imagining the Health System of the Future, a hospital-centric model emerges. The challenge in this hospital-centric view is that it ignores most ... Read More |
WHAT CLINICAL TEAMS SHOULD KNOW ABOUT CHANGING TRIAL LOGISTICS whitepaper Feb 20, 2019 When it comes to clinical supplies, the journey is every bit as important as the destination. And these days, the journey of clinical supplies to investigator sites is becoming costlier and more complex, much like the global trials for which the materials are bound. The price of failure is high. A s... Read More |
PHARMA 2020: CHALLENGING BUSINESS MODELS WHICH PATH WILL YOU TAKE? whitepaper Feb 20, 2019 The pharmaceutical marketplace is undergoing huge changes, as we indicated in “Pharma 2020: The vision”, the White Paper PricewaterhouseCoopers* published in June 2007.1 These changes will have a major bearing on the kind of business models pharmaceutical companies need to employ. Most B... Read More |
USING FLEXIBLE-CONTENT SYNDROMIC PANELS TO HELP MANAGE INFECTIOUS DISEASE whitepaper Feb 18, 2019 Recently, rapid advancements have been made in molecular testing technology for infectious diseases. This white paper briefly reviews those advances and discusses the choices laboratory managers face in light of them. We focus on flexible-content syndromic panels for respiratory, gastrointestinal, a... Read More |
MEASURING VOLATILE ORGANIC COMPOUNDS (VOCS) IN PHARMACEUTICALS whitepaper Feb 18, 2019 The monitoring of biotechnological fermentation processes, used for the production of modern biopharmaceutical drugs, is becoming ever more relevant for the promotion of economic production, particularly within the manufacturing sector. Up until now, biotechnical techniques have typically been monit... Read More |
|
PHARMA R&D ANNUAL REVIEW 2019 whitepaper Feb 15, 2019 Pharma R&D Annual Review 2019 is based on the stats and data from Pharmaprojects, part of Informa’s Citeline family of intelligence solutions. Authored for the 27th time by Ian Lloyd, Senior Director, Pharmaprojects, this whitepaper contains the whole nine yards. Read More |
RISING TO MEET HEALTHCARE INDUSTRY CHALLENGES whitepaper Feb 13, 2019 Discover what strategies healthcare organizations are undertaking to address the top issues that face them: addressing cost pressures resulting from declining reimbursements and improving the patient experience. Learn about the steps necessary to address these issues and become an intelligent enterp... Read More |
ARTIFICIAL INTELLIGENCE IN HEALTHCARE whitepaper Feb 12, 2019 Since the inception of electronic health record (EHR) systems, volumes of patient data have been collected, creating an atmosphere suitable for translating data into actionable intelligence. The growing field of artificial intelligence (AI) has created new technology that can tackle large data sets,... Read More |
MOLECULAR SPECTROSCOPY OF GLUES FOR QUALITY CONTROL AND DEVELOPMENT whitepaper Feb 12, 2019 Adhesives are indispensable in the automotive, aeronautic, and medical industries, among others. Modern adhesives are complex, and their quality requires an assessment of initial components as well as the final product. Molecular spectroscopy approaches, including FTIR and Raman, can be used to iden... Read More |
DETECTING PHARMACY FRAUD: IS YOUR BRAND’S CO-PAY PROGRAM PROTECTED? whitepaper Feb 12, 2019 The incidences of pharmacy fraud involving pharmaceutical manufacturers’ co-pay card programs are on the rise. In this white paper, TrialCard discusses the steps it has taken to expand its Pharmacy Fraud Monitoring service, which identifies fraud and greatly reduces the reimbursement funds tha... Read More |
AVOIDING HEMOLYSIS BLOOD SAMPLE COLLECTION PROCESSING whitepaper Feb 11, 2019 Depending on your point of view, red blood cells, or erythrocytes, are throwaways and a nuisance, ruining a good blood specimen if the cells burst and contaminate the sample. On the other hand, erythrocytes have significant value in specific types of research, and if your objective is biobanking the... Read More |
TAKING THE 'HIGH' OUT OF PAIN whitepaper Feb 04, 2019 Twenty years ago, there was a shift in pain management, and it became more common to prescribe opioids for chronic pain. Initially, physicians were misinformed that addiction to these medications was highly unlikely in a clinical setting, causing a shift towards prescribing opioids as the drug ... Read More |
ACHIEVING COMPETITIVE ADVANTAGE WITH ANATOMY AND PHYSIOLOGY whitepaper Feb 04, 2019 This whitepaper explores how best in class anatomy, physiology and clinical content, images and customised solutions enable organizations to achieve strong competitive advantage, drive credibility, productivity and differentiation. We will share ideas that you can consistently apply to your own orga... Read More |
IMPROVE PIPETTING OF VISCOUS LIQUIDS IN PHARMACEUTICAL FORMULATIONS whitepaper Feb 01, 2019 Whilst commonly used air displacement pipettes are highly accurate for most liquid dispensing applications, the viscosity, volatility, surface tension and temperature of the solution can adversely affect their performance. In pharmaceutical formulations, frequently used liquids, like glycerol, are m... Read More |
HITTING A BIOLOGICAL BULLSEYE WITH TARGETED SEQUENCE ANALYSIS whitepaper Jan 31, 2019 Cellular heterogeneity plays a critical role in systems and pathologies, but many genomic analysis techniques derive their findings from multicellular samples, potentially burying key information from individual cells or rare subsets. Next-generation sequencing-based single-cell whole transcriptome ... Read More |
POLYMERS FOR DRUG-DEVICE COMBINATION PRODUCTS whitepaper Jan 28, 2019 A wide variety of polymer types are available to the DDCP developer,
and many are available on the market that meet the necessary
regulatory requirements. Careful consideration should be given to
the choice of vendor to ensure that quality and consistency are
met. The ava... Read More |
|
|
THE LIFETIME VALUE OF PATIENT LOYALTY whitepaper Jan 21, 2019 Patient satisfaction is currently treated as one proxy for the quality of care a patient receives. Admittedly subjective, satisfaction survey scores are nonetheless put to all kinds of concrete purposes, from reimbursement to performance pay. While satisfaction scores undoubtedly help gauge the expe... Read More |
|
TOXIN NEUTRALIZATION USING ALTERNATIVE BINDING PROTEINS whitepaper Jan 17, 2019 Animal toxins present a major threat to human health worldwide, predominantly through snakebite envenomings, which are responsible for over 100,000 deaths each year. To date, the only available treatment against snakebite envenoming is plasma-derived antivenom. However, despite being key to limiting... Read More |
|
GROWING ATTENTION BEING PAID TO PHARMA COMPANY REBATES AND DISCOUNTS whitepaper Jan 14, 2019 Drug company rebates and discounts have always been an opaque aspect of the US pharma industry. There is little transparency in how much drug companies pay in rebates and discounts. Indications are it is annually in the tens of billions of dollars for the industry and growing. Price concessions can ... Read More |
SECURE STERILE TRANSFER IN PHARMACEUTICAL PRODUCTION whitepaper Jan 14, 2019 Sterile transfer of components and other materials between sterile and non-sterile areas has always been a major concern in the pharmaceutical production industry. Previously, injectables and other medicinal products were produced in conventional clean rooms with insufficient protective barrier syst... Read More |
|
GABAA RECEPTORS APPLICATION NOTE whitepaper Jan 11, 2019 GABAA receptors represent a large and complex family of ion channels that consist of at least 16 subunits (α1-6, β1-3, γ1-3, δ, ε, π, θ) and have been shown to be vital for the normal functioning of the brain. These ligand-gated chloride ion channels form pent... Read More |
INTRODUCTION TO MACHINE LEARNING IN HEALTHCARE whitepaper Jan 10, 2019 15 minutes. That’s how long your doctor has to see you, assess your complaint, diagnose a solution and see you out the door hopefully on the pathway back to wellness. This isn’t much time when you consider the wealth of information that he or she has to consider. Your patient record, the... Read More |
PROTECTING HEALTHCARE SOFTWARE whitepaper Jan 10, 2019 For decades medical devices have been standalone instruments that interacted only with the patient or medical provider. The advent of technological innovations including miniaturization, low power computation, and wireless technologies has created a new paradigm in the healthcare industry: the Inter... Read More |
|
PHARMA OUTLOOK 2030: FROM EVOLUTION TO REVOLUTION whitepaper Jan 07, 2019 The pharmaceutical sector is at a crossroads. In a heavily disrupted marketplace, characterized by shifting payer attitudes and patient empowerment, neither incremental adjustments nor steady evolution are likely to halt the decline of the traditional pharmaceutical business model. This paper looks ... Read More |
|
|
INTEGRATED BIOLOGICS: ENABLING HIGH THROUGHPUT DRUG DISCOVERY AT AMGEN whitepaper Jan 04, 2019 Large molecule discovery and development is a complex series of interwoven cycles that span many teams within a research and development organization. By making a commitment to informatics, Amgen pioneered the shift to large molecules and was on the forefront of addressing the complexity of large mo... Read More |
|
|
MUSCULOSKELETAL PROGRAM CLINICAL APPROPRIATENESS GUIDELINES whitepaper Jan 01, 2019 AIM’s Clinical Appropriateness Guidelines (hereinafter “AIM’s Clinical Appropriateness Guidelines” or the “Guidelines”) are designed to assist providers in making the most appropriate treatment decision for a specific clinical condition for an individual. As used ... Read More |
THE HEALTH AND TECH
TRENDS THAT WILL SHAPE
PHARMA MARKETING IN 2019 whitepaper Dec 28, 2018 Intouch’s annual trends report highlights the healthcare and tech trends that will shape the year ahead. You can look back and see our predictions for 2018, 2017, and 2016. And if you do, you might think — wait! Some of these trends look familiar from previous years! If so — you&rs... Read More |
|
CLOUD COMPUTING IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT whitepaper Dec 26, 2018 Cloud computing represents an IT service model which helps in the delivery of computing services, both hardware and software, to customers, on demand, over a network, which utilizes the internet. Thus, users only incur operating expenses associated with the time and length of usage, and are not requ... Read More |
EFFICIENT REMOVAL OF AGGREGATES FROM MONOCLONAL ANTIBODIES whitepaper Dec 26, 2018 Monoclonal antibody (mAb) therapeutics have been widely used to treat various diseases, including cancer. Oftentimes, dimers and other high molecular weight aggregates are present in the mAb therapeutics, leading to reduced biological activity. Traditionally-used methods for aggregate removal rely h... Read More |
|
|
2018 CONSUMER SURVEY ON DIGITAL HEALTH whitepaper Dec 14, 2018 Accenture commissioned a seven-country survey of 7,905 consumers aged 18+ to assess their attitudes toward healthcare technology, modernization and service innovation. The online survey included consumers across seven countries: Australia (1,031), England (1,043), Finland (848), Norway (768), Singap... Read More |
CONSIDERATIONS IN SELECTING A POPULATION HEALTH MANAGEMENT SOLUTION whitepaper Dec 12, 2018 The most essential requirement to enable the ability to move forward with confidence on a population health strategy is a solid foundation of data and information that is connected, complete, accurate, and available in real time. The rapid digitization of health data of all types ensures that data w... Read More |
RAPID STERILITY TESTING OF FILTERABLE SAMPLES whitepaper Dec 12, 2018 Sterility testing of final drug products is a mandatory release test for pharmaceutical companies and is critical to ensure patient safety. However, traditional methods such as membrane filtration require a minimum incubation time of 14 days. This long time to result in delays in product release and... Read More |
|
INDUSTRY TRENDS CHANGING STERILE FILTRATION whitepaper Dec 11, 2018 According to a recent report from the Tufts Center for the Study of Drug Development, the total price tag for bringing a new drug to market can be up to $2.7 billion.1 While development costs are high, keeping costs low during commercial production while delivering products that are safe for human u... Read More |
MULTI-OMICS IN CANCER RESEARCH whitepaper Dec 10, 2018 The genome has given clinical researchers a powerful tool for understanding the biological foundations of many diseases, but it only tells part of the story. This ebook shows how different laboratories are employing mass spectrometry and other cutting-edge tools to collect richer datasets based on a... Read More |
TECHNICAL DOCUMENTATION AND MEDICAL DEVICE REGULATION whitepaper Dec 05, 2018 Before placing a medical device on the European market, manufacturers need to produce technical documentation providing evidence of conformity with the relevant legislation. Technical documentation needs to be in compliance with the Medical Devices Directive (MDD) 93/42/EEC or the Active Implantable... Read More |
|
|
GENE THERAPY: A PARADIGM SHIFT IN MEDICINE whitepaper Nov 30, 2018 Gene therapy, the modification of genetic information in living cells to address a mutated gene, has the ability to dramatically change the way diseases are treated, or even cured. First conceptualized in the early 1970s, the seminal paper on the subject was published in Science by Theodore Friedman... Read More |
ONE PLANT'S SECRET FOR ASSURING ASEPTIC CONTROL whitepaper Nov 29, 2018 Airflow visualization testing, conducted as part of a routine review program, can help assure that aseptic filling areas remain under a state of proper control. In fact, ISO standards recommend frequent airflow measurements. ISO standard 14644-2 requires “specifications for testing and monitor... Read More |
SELECTING FILTERS TO ADDRESS YOUR BIOBURDEN CHALLENGES whitepaper Nov 28, 2018 Biologics development and manufacturing is inherently complex and challenging. Compounding this is the added pressure to be first to market in a highly competitive healthcare landscape, where delays can put the success of a product and company at risk. The implication for process development enginee... Read More |
|
DIGITAL PATHOLOGY IN ACCELERATING DRUG DEVELOPMENT whitepaper Nov 26, 2018 Tissue pathology is at the core of various aspects of the pharmaceutic pipeline. Digital pathology is a technology that converts glass microscope slides with tissue samples into whole slide digital images, which can be used to identify, quantify, and document key characteristics of tissue samples. T... Read More |
CURRENT THERAPEUTIC TARGETS FOR ALZHEIMER’S DISEASE whitepaper Nov 25, 2018 Alzheimer’s disease (AD) is one of the most common multifactorial diseases, including a range of abnormal cellular/molecular processes occurring in different regions of the brain. This disease is considered to be a major contributor to dementia in elderly people. The pathophysiology involves t... Read More |
|
WHAT PHARMA SHOULD DO ABOUT ARTIFICIAL INTELLIGENCE (AI) whitepaper Nov 22, 2018 AI has the potential to provide huge benefits to the pharmaceutical industry, from improving R&D productivity through to more effective sales representative deployment and better supply chain management. Adoption of AI is lagging other sectors, with initial forays mainly being led by big pharma ... Read More |
AUTHORIZED REPRESENTATIVES UNDER THE MDR whitepaper Nov 21, 2018 The EU Medical Devices Regulation 2017/745 (MDR) has significantly increased the burden of compliance and potential legal liability exposure for economic operators, including EU authorized representatives (ARs) of manufacturers established outside of the European Economic Area (EEA), Switzerland and... Read More |
TOP HEALTH INDUSTRY ISSUES OF 2019 whitepaper Nov 19, 2018 The US health industry has often lagged other industries—think tech, retail, hospitality when it comes to modernizing. Once thought to operate outside the greater US economy, the industry with its byzantine payment system, complicated regulatory barriers, and reliance on face-to-face interacti... Read More |
LENTIVIRUS 101: SIMPLE GENE DELIVERY whitepaper Nov 18, 2018 Lentiviruses are single-stranded RNA viruses and the second major subgroup of the retroviruses. Lentiviruses are powerful tools in molecular biology. They have long incubation periods and are capable of delivering relatively large loads of genetic information into the DNA of a broad range of cells w... Read More |
NATIONAL SERVICE FRAMEWORK FOR DIABETES whitepaper Nov 17, 2018 Less than a hundred years ago diabetes was a death warrant. The discovery of insulin in The 1920s was a major breakthrough. Since then, thanks to the dedicated work of scientists, researchers, doctors, and nurses in this country and abroad, there have been huge strides forward in our knowledge of di... Read More |
|
NON-DESTRUCTIVE HARDNESS TESTING whitepaper Nov 15, 2018 Tablet hardness testing plays an important role in pharmaceutical product development and quality control. In the race to streamline tablet hardness analysis, Advantest combines speed, simplicity and increased the precision with innovative and non-destructive terahertz (THz) metrology. Read More |
METABOLOMICS IN CANCER RESEARCH whitepaper Nov 14, 2018 Metabolomics is an emerging field of “omics” concerned with measuring and interpreting the metabolic state (i.e. metabolome) and is an essential technology for defining the key functional attributes of tumors or cancer cells. Read More |
INNOVATIONS IN CANCER SCREENING whitepaper Nov 13, 2018 How advances in imaging technology and the use of artificial intelligence and analytics are improving the accuracy and cost of medical imaging for early cancer diagnosis, and increasing confidence in vital preventive screening programs. Read More |
A LC-MS APPROACH TO SCREEN DRUGS IN DRUG CONSUMPTION ROOMS whitepaper Nov 13, 2018 In this study, the Toxtyper is used for drug screening in drug consumption rooms which are seen as an important element to minimize drug-related health problems (e.g. infection risk) and promote contact of drug users with employees of drug help programs. Read More |
WHAT HEALTHCARE ORGANIZATIONS SHOULD KNOW ABOUT THE GDPR whitepaper Nov 12, 2018 Data protection regulations define how an individual’s personal information can be used by organizations, businesses, and government. These regulations also contain safeguards that seek to ensure healthcare data is not susceptible to attack, misuse or misappropriation. As most know, misusing a... Read More |
THE ACCENTURE DIGITAL HEALTH TECHNOLOGY VISION 2017 whitepaper Nov 12, 2018 Technology for People shows the way to an exciting future where healthcare technology is designed by humans, for humans, to create positive change that can transform healthcare organizations and society. Digital breakthroughs are enabling healthcare enterprises to improve labor productivity, cl... Read More |
BE IMMORTAL whitepaper Nov 12, 2018 Immortality has long been treated as a work of fiction - a trait only possessed by mythological Gods and divine creatures. Is there an afterlife or life after death? Each religion or system of belief had its own way to deal with such questions. Certain scientists and philosophers, writers have theor... Read More |
EMERGING TRENDS AND TECHNOLOGY-CLINICAL TRIALS DATA AS RDF whitepaper Nov 12, 2018 This white paper outlines the philosophy, methods, and deliverables for the PhUSE Computational Sciences Symposium Emerging Trends and Technology working group project “Clinical Trials Data as RDF.” The project was formed to investigate the feasibility of using Linked Data as a future-pr... Read More |
HOW TO BUILD AND SUSTAIN A ‘CAPABLE’ HEALTHCARE SYSTEM whitepaper Nov 10, 2018 What matters most when building and sustaining a healthcare organization? What are the precise levers to pull to promote physician well being, financial success, and better outcomes at lower cost? To answer these questions, Athena health launched an ongoing research project in 2016. Now in its secon... Read More |
ANALYSIS AND COMPLIANCE IN PHARMACEUTICALS whitepaper Nov 10, 2018 Pharmaceuticals play a prominent role worldwide. This widespread presence is met with regulatory requirements at each phase of pharmaceutical development and manufacturing—from inspection of raw materials to quality control of final products. Consistently producing pharmaceuticals that both co... Read More |
2017 CLINICAL TRIALS ROUNDUP THE EVOLUTION CONTINUES whitepaper Nov 08, 2018 The landscape of clinical trials continues to evolve over time as scientific breakthroughs and technological innovations emerge, which continue to be tracked by assessing recently initiated trials through Trialtrove’s annual Clinical Trials Roundup. Read More |
REFORMING AMERICA’S HEALTHCARE SYSTEM THROUGH CHOICE AND COMPETITION whitepaper Nov 08, 2018 On October 12, 2017, through Executive Order 13813, you directed the Administration, to the extent consistent with the law, to facilitate the development and operation of a health care system that provides high-quality care at affordable prices for the American people by promoting choice and competi... Read More |
|
A HEARING HEALTH BENEFIT whitepaper Nov 06, 2018 Across the country, hearing health is becoming a hot topic of conversation and it’s grabbing the attention of the organizations that deliver health care benefits to millions of Americans. Driving this phenomenon are several wide-ranging factors as shown below. Read More |
A DIGITAL HEALTH INTELLIGENCE WHITE PAPER SUPPORTED BY SAMSUNG whitepaper Nov 05, 2018 This white paper represents a key piece of research into the potential benefits of mobile working in healthcare and considers the obstacles that will have to be surmounted along the way. Given our research was conducted in the aftermath of last May’s WannaCry attack, it will come as little sur... Read More |
DEPRESSION NEW INSIGHTS SHIFTING THE TREATMENT PARADIGM WHITEPAPER whitepaper Nov 05, 2018 Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are in Depression: New Insights Shifting the Treatment Paradigm. Read More |
|
STATE TELEHEALTH LAWS & REIMBURSEMENT POLICIES whitepaper Nov 02, 2018 The Center for Connected Health Policy’s (CCHP) Fall 2018 release of its report on “State Telehealth Laws and Reimbursement Policies” offers policymakers, health advocates, and other interested health care professionals a freshly redesigned summary guide of telehealth-related polic... Read More |
UTILIZING EXTERNAL COLLABORATION TO ACCELERATE VACCINE DEVELOPMENT whitepaper Nov 02, 2018 As the pharmaceutical industry continues to look for new and innovative ways to treat disease, some companies are putting more focus on how to prevent them. Vaccine development, while a long and complex process, has the potential to save millions of lives globally, especially in low-income countries... Read More |
TRANSFORMING HEALTHCARE IT WITH ENTERPRISE CLOUD whitepaper Nov 02, 2018 A Nutanix enterprise cloud reduces the cost and complexity of IT infrastructure for healthcare while improving scaling, availability, and data protection. Conventional infrastructure is no longer able to address healthcare challenges, such as regulatory hurdles, resource constraints, highly mobile w... Read More |
RAMAN SPECTROSCOPY TOOLS TECHNIQUES APPLICATIONS whitepaper Oct 30, 2018 Raman spectroscopy has taken large strides in recent years as more Raman vendors have developed handheld Raman units capable of carrying out raw material identification or verification. Raman spectroscopy is used as a fingerprinting tool to capture the unique Raman spectrum of each raw material. The... Read More |
|
METHODS FOR DEFORMULATING DRUGS whitepaper Oct 25, 2018 The FDA has a number of regulatory routes through which a company can seek approval for a generic drug. The most notable is the Abbreviated New Drug Application (ANDA) route whereby a generic company develops an exact copy of the innovator product and can use the safety and efficacy data from the in... Read More |
|
HOSPITAL PHARMACIES OFFER AN UNTAPPED SOURCE OF POWERFUL COST SAVINGS whitepaper Oct 19, 2018 Facing increasing margin pressures—and having already implemented many proven cost reduction and revenue-increasing measures—hospitals and health systems have to find new ways of reducing their costs without compromising quality or patient safety. By drawing on the expertise of their pha... Read More |
|
2017 COMPLETED TRIALS whitepaper Oct 18, 2018 As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were a total of 3,534 Phase I through Phase III/IV. The nearly 700 trials terminated in 2017 were not included in this an... Read More |
BENEFITS OF HARD X-RADIATION whitepaper Oct 15, 2018 This white paper outlines the main benefits of using hard radiation for material analysis studies. X-ray powder diffractometers are generally equipped with X-ray sources using Cu anodes. For specific applications, however, switching to shorter wavelength, ‘harder’ radiation, like obtaine... Read More |
DEVELOPING AND MAINTAINING A QUALITY MANAGEMENT SYSTEM FOR IVDS whitepaper Oct 12, 2018 There are many different requirements with which in vitro diagnostic manufacturers must comply in order to place the product on the market. At the core of most of these requirements is a fundamental need to have a good quality management system (QMS) in place. This is certainly not a new requirement... Read More |
PHARMA PARTNERING TRENDS REVEALED WHITEPAPER whitepaper Oct 12, 2018 Make the most of BIO-Europe 2018 with essential partnering information from Informa Pharma Intelligence. Our insightful whitepaper, Pharma Partnering Trends Revealed: 2018 Edition, contains critical information on the landscape for biotech partnerships and is now available for you to download &ndash... Read More |
DRIVING SALES BEHAVIOR WITH NON-CASH REWARDS whitepaper Oct 03, 2018 In the end, you need to be rewarding your sales reps with more than just money if you want to keep them motivated and if you want your sales compensation plan to deliver on its promises. Read More |
CHANGE THE SALES REP EXPERIENCE, IMPROVE THE CUSTOMER EXPERIENCE whitepaper Oct 03, 2018 The first CRM launch truly changed the way sales were managed. We went from tracking customers on spreadsheets (and even in rolodexes) to tracking them and their attendant opportunities with software. It wasn’t long before reps started to feel the purpose of a CRM was more about preserving the... Read More |
|
|
CYBERSECURITY IN THE AGE OF MEDICAL DEVICES whitepaper Sep 28, 2018 Countless studies and articles have confirmed that connected medical devices from implantable products like pacemakers to diagnostic devices such as CT scanners and more are indeed vulnerable to malicious exploitation. This paper offers both technical and nontechnical solutions to help prevent and m... Read More |
THE EVOLUTION OF ANTIBODY-DRUG MANUFACTURING whitepaper Sep 27, 2018 Even before the 1980s, the notion of attaching a cytotoxic agent to a tumorspecific antibody captured the collective imagination of the international drug development community. Were antibodydrug conjugates (ADCs) the magic bullets everyone was looking for that could, among other things, cure cancer... Read More |
DRUG SUBSTANCE SOLID STATE CHARACTERIZATION whitepaper Sep 27, 2018 A thorough knowledge of an active pharmaceutical ingredient’s (API) solid state behavior is essential for reliable drug product manufacturing, patent protection, and formulation viability. This article discusses various aspects of the API in the solid state which can impact pharmaceutical prod... Read More |
ADVANCING HUMAN GENETICS RESEARCH WITH NANOPORE SEQUENCING whitepaper Sep 26, 2018 High-throughput sequencing technologies have revolutionized the field of human genetics, allowing researchers to more easily investigate and understand biological processes and their impact. Using these technologies, researchers can analyze entire genomes or specific targeted regions of interest, wi... Read More |
BLOCKCHAIN ADOPTION IN PHARMA SUPPLY whitepaper Sep 24, 2018 Experts have asserted that despite recent developments, pharmaceutical supply chains are still far from reaching their full technological potential. Blockchain holds significant promise to advance the digital strength of medicine supply. Read More |
|
MEDICAL DEVICES 2030 whitepaper Sep 21, 2018 While the outlook for medical device companies appears positive, unsustainable health care costs and new competitive forces threaten to alter the future industry landscape. If today’s manufacturers fail to stake their claim in the evolving value chain, they risk being caught in the middle and ... Read More |
TOP 4 NETWORK SECURITY CHALLENGES IN HEALTHCARE whitepaper Sep 19, 2018 CIO’s and IT professionals in healthcare organizations are tasked with achieving a balance between the demand for universal access to information and the need to ensure security. In particular, four critical challenges these organizations face in terms of striking this balance include the foll... Read More |
UNDERSTANDING AND DEFINING LABORATORY CAPACITY IN BIOPHARMA whitepaper Sep 18, 2018 Has anyone asked you, "What is your laboratory capacity?" In the scientific world of planning laboratories, defining capacity is not so straightforward. This makes answering the question challenging unless you have a method in place. The reality is, you have options for measuring your labo... Read More |
ENABLING GENOMICS-GUIDED PRECISION MEDICINE whitepaper Sep 18, 2018 The era of precision medicine has arrived, and with it, a tidal wave of data from disparate sources, including electronic health records (EHRs), lab systems, pathology, and genomics. By integrating data from all available sources and analyzing it in smart ways, clinicians can finally get a complete ... Read More |
THE DENTIST’S GUIDE TO PATIENT FINANCING whitepaper Sep 17, 2018 If you’ve ever bought a car, remodeled a room in your home, or shopping for a high-end TV, chances are the business you purchased from offered you a financing plan. The appeal of financing is simple: it helps people buy things they normally couldn’t afford. Financing is a convenient solu... Read More |
BLOOD CONSERVATION WITH A PATIENT DEDICATED ARTERIAL BLOOD GAS ANALYSER whitepaper Sep 16, 2018 Anemia is a frequent complication of critical care, with up to 90% of ICU (Intensive Care Unit) patients being anemic by their third day in the ICU1. Anemia is associated with poor patient outcomes, especially amongst those patients with cardiovascular disease2345. The treatments of choice for anemi... Read More |
|
THE EUROPEAN MEDICAL DEVICES REGULATIONS whitepaper Sep 15, 2018 The publication of the stable text of the European Union (EU) Medical Devices Regulation (MDR), and the In Vitro Diagnostic Medical Devices Regulation (IVDR), in June 2016 documented political agreement between the three EU Institutions – the Commission, the Parliament, and the Council –... Read More |
THE FUTURE OF THE HEALTHCARE MARKET REACTION DATA - 2018 whitepaper Sep 15, 2018 The healthcare IT landscape continues to change. One minute you’re convinced the world is round and then a series of new technological advancements, entrants into the market, and mergers and acquisitions give it the appearance of being flat. Then news breaks and it becomes a Rubik’s cube... Read More |
|
PHARMA PARTNERING TRENDS REVEALED: 2018 EDITION whitepaper Sep 09, 2018 When you experience the choreography of tens of thousands of face-to-face meetings at BIO-Europe®, you know for certain that partnering is still the deal in the biotech industry. From nearly 1,000 partnering booths, executives from across the industry value chain pitch assets, exchange ideas, an... Read More |
ENABLING DATA INTEGRITY FROM DRUG DISCOVERY THROUGH MANUFACTURING whitepaper Sep 06, 2018 When discussing the success of a drug therapy, a common topic amongst biopharmaceutical companies is data quality and data integrity; what the challenges are and what the key elements are to ensuring that the latest discovery is patentable, does not result in re-conducting critical research or devel... Read More |
BIOSIMILARS: REGULATORY TRENDS AND MANUFACTURING CONSIDERATIONS whitepaper Aug 28, 2018 Unlike well-defined chemical medicinal products and their generic counterparts, biologics and their biosimilar counterparts employ sophisticated bioprocessing technologies that utilize living systems for their manufacture. Because these complex heterogeneous protein molecules are produced in living ... Read More |
FHIR FINALLY BRINGS THE INTERNET TO BEAR ON HEALTHCARE’S BIG DATA whitepaper Aug 27, 2018 Pervading every facet of daily life, the information superhighway that society has come to know and love – and occasionally loathe – has enabled a level of communication, collaboration, insight, and analysis that has rendered the current generation of smartphone-addicted kindergarten cod... Read More |
HPLC VS UHPLC whitepaper Aug 24, 2018 Liquid chromatography is a technique of key importance for many areas of chemical analysis and one that has evolved with the progression of technology and instrumentation over time. Here we highlight some of the key similarities and differences between high-performance liquid chromatography (HPLC) a... Read More |
CONTACT CENTERS IN HEALTHCARE: A REPORT FOR HOSPITAL LEADERS whitepaper Aug 22, 2018 Fifty-one percent of national survey respondents say they’ve had a contact center strategy in place 3 – 5 years, and 48 percent call their strategy an enterprise transformation initiative. Can maximizing this resource take your hospital into the future? See what your peers are saying abo... Read More |
|
4 TOP TRENDS IN HEALTHCARE DATA ANALYSIS TO ADOPT TODAY whitepaper Aug 18, 2018 The healthcare industry has never been more focused on data its promise and its pitfalls as it is today. From slashing health care spending to detecting fraud or coordinating care across multiple providers improved the use of healthcare data has been held up as a “silver bullet” to slay ... Read More |
THE KEY TO IMPROVING THE MODERN PATIENT EXPERIENCE whitepaper Aug 15, 2018 The patient experience is the sum of all the interactions had with a healthcare organization. Therefore, the experience itself hasn't confined to the walls of a hospital or the examination rooms of an outpatient clinic the experience starts anywhere and anytime the patient first encounters the h... Read More |
UNDERSTANDING CLOUD SECURITY IN HEALTHCARE whitepaper Aug 12, 2018 Cloud computing is having a profound impact on healthcare. The healthcare cloud computing market is projected to almost triple between 2015 and 2020 to $9.48 billion.1 In the same time period, the Internet of Things (IoT) the number of devices connected to the Internet is projected to double to 40.9... Read More |
|
ADAPTATION AND CONSERVATION INSIGHTS FROM THE KOALA GENOME whitepaper Aug 08, 2018 The koala, the only extant species of the marsupial family Phascolarctidae, is classified as ‘vulnerable’ due to habitat loss and widespread disease. We sequenced the koala genome, producing a complete and contiguous marsupial reference genome, including centromeres. We reveal that the k... Read More |
TRANSITIONAL CARE MANAGEMENT: CONNECTING TO CARE whitepaper Aug 08, 2018 Transitional care encompasses a broad range of services and environments designed to promote the safe and timely passage of patients between levels of health care, across care settings, and among various providers. Care settings can include a range of points of care such as hospitals, long-term care... Read More |
THE GENETIC BLOCKCHAIN ECOSYSTEM whitepaper Aug 08, 2018 DNAtix intends to create a future ecosystem for Genetics where consumers, researchers, laboratories, and clinics operate making Genetics more accessible, transparent and anonymous. DNAtix intends to offer cutting-edge Genetics and Blockchain services which intend to be anonymous and encrypted and in... Read More |
PCR: AMPLIFIED TO THE END POINT whitepaper Aug 08, 2018 30 years ago, polymerase chain reaction (PCR) burst onto the scene and steadily became one of the most common procedures in the lab. Advanced technologies have made it possible to achieve more accurate copies in a fraction of the time, no matter which of the several PCR-based methods you use. PCR is... Read More |
|
NEUROMATION whitepaper Jul 30, 2018 Artificial Intelligence (AI) is seeing another spring and becoming a ubiquitous part of society. Researchers and engineers have made important steps towards solving practical problems in machine learning, particularly in such applications as vision, speech, machine translation, and decision making. Read More |
HOW TECHNOLOGY IS REVEALING THE BIG PICTURE IN PHARMA whitepaper Jul 24, 2018 The collection and analysis of data generated outside of restricted clinical trials are now critical to pharma companies. Data gathered in the routine delivery of healthcare can be mined to uncover insights into treatment efficacies and outcomes in the real world. Such insights, known as real-world ... Read More |
INCENTIVE COMPENSATION MANAGEMENT: BUILD VERSUS BUY whitepaper Jul 23, 2018 Custom ICM solutions are built for you, not auditors, so they typically don’t offer visibility into actions performed over time. Auditors may lack confidence in your homegrown system, especially if they find errors or omissions. In fact, audit risk from errors and overpayments is often the mos... Read More |
THE THREE “S’S” OF A GREAT INCENTIVE COMPENSATION MANAGEMENT SYSTEM whitepaper Jul 23, 2018 It all ties together. You want your sales reps to behave a certain way and close a certain amount of deals in specific verticals that match your company’s 3- and/or 5-year vision, but the systems you currently have in place to drive this behavior are not working for any number of reasons. Most... Read More |
WHY ENTERPRISE CPQ IMPLEMENTATIONS FAIL whitepaper Jul 23, 2018 You’ve reached a certain point in the evolution of your company and you know it’s time to invest in a CPQ system. But buyer beware: There’s a certain misconception around CPQ systems as being plug-in devices or turnkey-ready overlays of your existing infrastructure, or a simple app... Read More |
MOVING AWAY FROM SPREADSHEETS: HOW TO KNOW WHEN IT’S TIME whitepaper Jul 23, 2018 The spreadsheet conundrum... Joe Smith, sales director for Great Start-Up Number 5 Billion and Thirty-One, puts on a blindfold and reaches out blindly for something, ANYTHING, to help him organize his team’s deals and commissions. He’s hopeful. He’s waiting. He knows he’ll co... Read More |
|
|
ALZHEIMERS DISEASE whitepaper Jul 12, 2018 Alzheimer’s Disease (AD) is the most common form of dementia and accounts for 60% to 80% of dementia cases. In this progressive disease, dementia symptoms gradually worsen over a number of years. Memory loss is mild during the early stages, but individuals with late-stage Alzheimer's lose ... Read More |
OPPORTUNITIES IN PRECLINICAL DEVELOPMENT whitepaper Jul 11, 2018 This whitepaper explains how you can find ways to optimize the holistic preclinical development process. When it comes to informatics and data management, each preclinical domain is characterized by specific requirements due to their diverse scientific needs. This whitepaper explains how you can fin... Read More |
HEALTHCARE COMMERCE AS A USER-FRIENDLY EXPERIENCE whitepaper Jul 07, 2018 Technological advancements occur with such frequency that it’s challenging to stay on top — or ahead — of the Next Big Thing, but successful businesses need to focus attention on advancements that make internal processes easier and more efficient. Highly successful businesses take ... Read More |
2016 NATIONAL HEALTHCARE QUALITY AND DISPARITIES REPORT whitepaper Jul 07, 2018 For the 14th year in a row, AHRQ is reporting on health care quality and disparities. The annual National Healthcare Quality and Disparities Report (QDR) is mandated by Congress to provide a comprehensive overview of the quality of health care received by the general U.S. population and disparities ... Read More |
TUFTS CSDD-VEEVA ECLINICAL STUDY CRO REPORT whitepaper Jul 06, 2018 See results from the Tufts eClinical Landscape Study – CRO Report on current data management practices, goals, and challenges for contract research organizations (CROs). Findings include. Anticipated growth and variety of data sources used by CROs. CROs’ biggest challenges with clinical ... Read More |
YOUR JOURNEY TO CLOUD IN HEALTHCARE whitepaper Jul 05, 2018 As the cloud becomes more prevalent, healthcare leaders are finding themselves in a multi-cloud environment, moving beyond basic infrastructure on demand to strategic innovations such as running real-time data analytics for the management of chronic disease patients. Read More |
IDEAS TO MAKE HEALTH CARE AFFORDABLE AGAIN whitepaper Jun 29, 2018 More Americans are concerned about health care costs (85%) that are concerned about other common worries like retirement (73%), housing (66%), and child care (49%).1 While Republicans, Democrats, and independents are divided over many healthcare issues, everyone agrees that the top health care prior... Read More |
ACCELERATING THE JOURNEY FROM RESEARCH TO CLINIC whitepaper Jun 26, 2018 Bridging the gap from discovery to verification and validation requires high-performing instruments and software as well as competency in mass spec-based biomarker discovery and method development for biomarker verification. The Thermo Scientific™ Q Exactive™ HF-X mass spectrometer rises... Read More |
REGULATORY CONSIDERATIONS FOR INCORPORATING PCID INTO SODF DRUGS whitepaper Jun 23, 2018 Unauthorized diversion and falsification of drug products create safety risks in the supply chain, creating life-threatening risk for patients and reducing revenue, profitability and brand equity for drug owners. To reduce the proliferation of counterfeit drugs in the U.S., the Drug Quality and... Read More |
MORTALITY DATA IN HEALTHCARE ANALYTICS whitepaper Jun 19, 2018 The incorporation of mortality data into healthcare data sets allows fraud prevention, accurate billing, and benefits distribution, and true outcome analysis (especially in fatal disease areas like oncology, where survival is a key endpoint). The net effect of adding mortality data is strengthening ... Read More |
IMPROVING PATIENT MATCHING WITH A SIMPLE PLUG-IN whitepaper Jun 19, 2018 Accurate patient matching is becoming 10 times more challenging and 10 times more critical. Instantly and dramatically improve your EHR’s or EMPI’s patient matching without disrupting any of its core functionality. By injecting the power of Referential Matching, you will get the full val... Read More |
IMMUNO-ONCOLOGY ADVANCES IN APPLIED CELLULAR ANALYSIS whitepaper Jun 18, 2018 For immuno-oncology research and the hunt for new immunotherapies, scientists are required to reliably quantify the functions and interactions of cancer cells and immune cells. Cell proliferation assays of tumor growth are a mainstay. Activation and proliferation assays for immune cells are also use... Read More |
MEDICAL COST TREND: BEHIND THE NUMBERS 2019 whitepaper Jun 16, 2018 Employer medical cost trend has plateaued. While the predictability is a welcome change from the wild swings and peak double-digit trends in the 2000s, steady as she goes is not good enough. Medical costs continue to grow as a percent of total employee compensation, making even the current trend uns... Read More |
PROMOTING HEALTH, PREVENTING DISEASE whitepaper Jun 15, 2018 The views expressed by authors or editors do not necessarily represent the decisions or the stated policies of the European Observatory on Health Systems and Policies or any of its partners. The designations employed and the presentation of the material in this publication do not imply the expressio... Read More |
REPRESENTATIVE ANALYSIS RESULTS REQUIRE ADEQUATE SAMPLE PREPARATION whitepaper Jun 15, 2018 The following situation is typical for many production plants: After a routine quality check, the production process is stopped or an already produced batch is suspended because the analysis results were not within the relevant critical values. But does the tested product really deviate from the spe... Read More |
THE IMPACT OF THE CLINICAL EDUCATOR whitepaper Jun 12, 2018 From passive consumer to active participant, the role of the patient is changing as dramatically as the healthcare system itself. The fee-for-service, volume-based care of the past is giving way to a value-based care system focusing on quality and outcomes. The new system seeks to reduce skyroc... Read More |
|
WORLD HEALTH STATISTICS 2018 whitepaper Jun 06, 2018 The World Health Statistics series is WHO’s annual compilation of health statistics for its 194 Member States. The series is produced by the WHO Department of Information, Evidence, and Research, of the Health Metrics and Measurement Cluster, in collaboration with all relevant WHO technical de... Read More |
STREAMLINING PATIENT PAYMENT FOR BETTER REVENUE CYCLE MANAGEMENT whitepaper Jun 06, 2018 Healthcare providers need to rethink their current patient payment collections strategy, thanks to two recent phenomena: high-deductible plans that are shifting a greater portion of the bill to the patient, and an increase in the number of patients struggling to pay those higher bills. Read More |
OPIOIDS AND PAIN: A PAN-EUROPEAN CHALLENGE whitepaper Jun 06, 2018 The aim of this White Paper is to identify inequalities in government policies towards opioids that contribute to the inadequate treatment of pain. It calls for their replacement with policies that will support doctors and patients in their efforts to relieve pain. Read More |
STREAMLINING “LIBRARY-TO-LEAD” FOR YOUR ANTIBODY THERAPEUTICS whitepaper Jun 06, 2018 The number of therapeutic antibodies entering the market continues to grow annually, with 2017 seeing ten approvals in either the European Union or the United States supported by a robust late-stage clinical pipeline that will likely yield even more approved drugs in 2018 and 2019. Making a drug is ... Read More |
PRICING GUIDE: ELECTRONIC MEDICAL RECORDS SOFTWARE whitepaper Jun 05, 2018 When choosing an EMR system, you need to consider what you will be charged for and when, in addition to how much. This highly visual guide offers a clear explanation of how various pricing models work, along with actual pricing for popular EMR and Practice Management software packages. Read More |
THE FUTURE OF THE PHARMACEUTICAL INDUSTRY whitepaper Jun 05, 2018 Ever participated in one of those benchmarking exercises? You know what I mean. When a (usually) fresh-faced consultant asks lots of questions and fills in a spreadsheet comparing what you do with your competitors. Well, beware. Trying to copy and follow others in a world of turbulence and massive u... Read More |
PATIENT-CENTERED HEALTH CARE VIA PATIENT-GENERATED HEALTH DATA whitepaper Jun 05, 2018 Millennials are quickly becoming the dominant health care consumers, both for themselves, their families and as caregivers. Having grown up in a technology-first environment, however, they are increasingly dissatisfied with the static nature of health care options and are seeking out alternatives. N... Read More |
HOW TO EXTEND IDENTITY SECURITY TO YOUR API’S whitepaper May 25, 2018 The number of users and devices requesting access to applications is growing exponentially, and enterprises are scrambling to adapt their authentication and authorization infrastructure to deal with this fast growth. REST APIs are a critical new application access channel. In a sense, REST APIs are ... Read More |
SELECTING THE RIGHT EHR FOR YOUR PRACTICE whitepaper May 22, 2018 According to a recent study conducted by AmericanEHR, nearly 40 percent of physicians would not recommend their EHR solution to another provider; only slightly fewer said they would not purchase the same software again. Conversely, a study conducted this year by an EHR vendor, the approximately 60 p... Read More |
PATIENT COMMUNICATION GUIDE whitepaper May 19, 2018 This guide outlines some simple strategies and tips for improving communication with your patients. Research indicates that ‘soft skills’ have a direct bearing on patient perceptions of the value of care provided, the degree of trust placed in the dentist and the success of treatment. Al... Read More |
SCALABLE STRATEGIES FOR PARENTERAL DOSAGE FORM SELECTION whitepaper May 17, 2018 There are many parenteral dosage forms from which the pharmaceutical scientist can choose to develop their drug product. For primary pack choices, there are traditional vials, ampoules, cartridges, pre-filled syringes and complex containers such as the various types of dual chamber syringes. Additio... Read More |
ANTIBODY SCREENING SOLUTIONS MADE EASY whitepaper May 16, 2018 With breakthroughs in molecular engineering and antibody humanization, monoclonal antibodies (Mab) are one of the fastest-growing classes of biopharmaceuticals for multiple clinical indications including cancer, cardiovascular disease, autoimmune disorders, and infectious disease. Most therapeutic a... Read More |
MEDICALCHAIN whitepaper May 16, 2018 The information set forth below may not be exhaustive and does not imply any elements of a contractual relationship. While we make every effort to ensure that any material in this whitepaper is accurate and up to date, such as products, services, technical architecture, token distribution, company t... Read More |
|
MANUFACTURING OF STERILE AQUEOUS SUSPENSIONS: A PRIMER whitepaper May 15, 2018 Manufacturing of sterile aqueous suspensions requires the thorough understanding of the factors that influence their physical and chemical stability. Particle morphology of the active pharmaceutical ingredient (API) plays a key factor in drug product dissolution rate, resuspendability, and syringeab... Read More |
PHARMA R&D ANNUAL REVIEW 2018 whitepaper May 15, 2018 Citeline’s Pharmaprojects’ Pharma R&D Annual Review 2018 is here! Tune into expert insights and score illuminating data on the trends that affected pharmaceutical R&D throughout 2017 and continue to shape the market today – for free. Read More |
DIGITAL HEALTHCARE MARKETING AND ENGAGEMENT SOLUTIONS whitepaper May 10, 2018 Truven Health Analytics™ offers a full suite of digital marketing and engagement services and support for healthcare organizations. These services range from email list management and execution; to multilayered, multimodal, lead nurturing campaigns; to fully automated patient engagement messag... Read More |
|
AVOID CLINICAL TRIAL ENROLLMENT PITFALLS whitepaper May 06, 2018 Selecting the right site is the single most crucial decision
you’ll make about your next clinical trial. And perhaps the
single most important consideration in selecting a site is
whether it can make its enrollment. Many don’t; in fact,
20-25 percent of all cl... Read More |
THREE LESSONS LEARNED TO ACHIEVE VALUE-BASED CARE SUCCESS whitepaper May 05, 2018 Commonwealth Physicians (Commonwealth)* is a physician-owned multi-specialty, the multi-location practice that serves more than 500,000 patients and is comprised of 25 practices and nearly 100 primary care providers. For Commonwealth Physicians, the Affordable Care Act (ACA) created the impetu... Read More |
A NEW VISION FOR COMPREHENSIVE CARE COORDINATION whitepaper May 05, 2018 Transitioning patients between outpatient, inpatient, post-acute and home settings can be a major challenge for hospitals. For organizations participating in value-based reimbursement models, it can also be costly. This case study examines how Holyoke (Mass.) Medical Center redesigned its care manag... Read More |
|
|
THE FUTURE OF DIGITAL HEALTH whitepaper May 02, 2018 The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution. The importance of successfully executing a digital health strategy, as well as creating new financial models and partnerships, cannot be under... Read More |
NAVIGATING PATIENT PAYMENT CONVERSATIONS WITH FINANCIAL COUNSELING whitepaper May 01, 2018 Many healthcare organizations depend on the work of financial counselors to help patients understand both their insurance coverage and their financial obligations. These professionals help patients make smart choices by answering questions about the cost of healthcare services, setting up payment pl... Read More |
PHARMA CONSULTING WHITEPAPER whitepaper Apr 30, 2018 Accurate benchmarking has never been more important to the biopharma industry than now, with increased scrutiny related to development costs at an all-time high. What benchmarks are you using? How does your development program compare to those of your competitors? Explore the importance of benchmark... Read More |
|
DIGITAL PATHOLOGY IN ACCELERATING DRUG DEVELOPMENT whitepaper Apr 25, 2018 Tissue pathology is at the core of various aspects of the pharmaceutic pipeline. Digital pathology is a technology that converts glass microscope slides with tissue samples into whole slide digital images, which can be used to identify, quantify, and document key characteristics of tissue samples. T... Read More |
8 REASONS WHY IT’S TIME TO UPGRADE TO AUTOMATED IMAGING whitepaper Apr 25, 2018 Automated image analysis systems that provide detailed morphological information are rapidly replacing manual microscopy as the most effective method of characterizing both particle shape and size. These sophisticated new instruments use the latest technology to provide useful and actionable insight... Read More |
THE USE OF EDXRF FOR PHARMACEUTICAL MATERIAL ELEMENTAL ANALYSIS whitepaper Apr 24, 2018 The recent changes to the United States Pharmacopeia (USP) regarding requirements for elemental impurity testing has peaked interest into new ways to perform this testing. Combining these new requirements with the introduction of USP chapter <735> X-ray fluorescence spectrometry1 permits a new... Read More |
ANALYSIS OF MICROPLASTICS USING FTIR IMAGING whitepaper Apr 19, 2018 As plastics continue to enter the environment, understanding their global impact is vital to addressing microplastic pollution. Since its emergence as an environmental and potential human health threat, researchers have strived to develop tools for accurately measuring microplastics in environmental... Read More |
|
ALIGNING STAKEHOLDERS IN A NEW HEALTHCARE ECOSYSTEM whitepaper Apr 05, 2018 Preventable chronic diseases such as diabetes, cardiovascular disease, and cancers are responsible for over 40 of the 56 million annual deaths worldwide (7 out of every 10 deaths). Our medical communities spend vast resources battling complications of these behavior-related conditions, despite the a... Read More |
2018 JP MORGAN HEALTHCARE CONFERENCE REVIEW whitepaper Apr 05, 2018 Don't miss out on this comprehensive review of all the presentations from the conference, compiled by our analysts, with key points and expert insight, for you to download, for free. A full list of events and catalysts that were announced or updated during the conference is included in this repo... Read More |
|
THE VALUE OF FULL-LENGTH TRANSCRIPTS WITHOUT BIAS whitepaper Mar 28, 2018 RNA sequencing (referred to as RNA-Seq with traditional sequencing technologies) has led to unprecedented advances in all fields of biology and medicine. It has been an invaluable tool for the study of human genetics and the pathology associated with the disease. Transcript isoform expression and us... Read More |
NOVEL BIOLOGICS - ASTHMA whitepaper Mar 22, 2018 Download this white paper, which looks at novel biologics in development for the treatment of uncontrolled, eosinophilic asthma and whether they can fulfill the promise of truly targeted therapies for one of the most prevalent respiratory diseases worldwide. Novel Biologics for Asthma: Steps on the ... Read More |
PRODUCT LIFECYCLE MANAGEMENT FOR THE PHARMACEUTICAL INDUSTRY whitepaper Mar 21, 2018 In recent years the pharmaceutical industry has faced declining R&D productivity, a rapidly changing healthcare landscape and fierce competition from generics resulting in lower growth and profit margins. Historically, drug development focused on clinical trials management and outcomes. Now howe... Read More |
THE BENEFITS OF AQUEOUS CRITICAL CLEANING whitepaper Mar 20, 2018 Aqueous cleaners are typically formulated to ensure maximal cleaning performance by using key ingredients such as surface active agents (surfactants) excellent wetting agents that allow the cleaning solution to penetrate into crevices while getting under soils to allow for removal. Often very dilute... Read More |
AN ANALYSIS OF DRUG THERAPY TAPERING GUIDELINES whitepaper Mar 16, 2018 Chronic pain, the kind of pain a person wakes up with every morning and goes to sleep with every night, has a standard of care that is often incomplete and sometimes inaccurate. Chronic pain treatment often revolves around drug therapy and managing side effects without addressing non-drug therapies ... Read More |
ANALYSIS USING COUNTER-ROTATING TWIN SCREW EXTRUDER whitepaper Mar 14, 2018 While the co-rotating, intermeshing TSE is more commonly used in pharmaceutical R&D and production, the counter-rotating, intermeshing TSE is a viable tool to successfully process these formulations. Energy input must be strategically balanced to perform mixing functions without degradation of A... Read More |
PATHEON’S SOLID AND STERILE DOSAGE FORMS BROCHURE whitepaper Mar 14, 2018 By partnering with Patheon, you have access to a remarkable range of dosage form technologies for oral solids. Take advantage of our expansive scientific resources and expertise to create a product that stands out in the marketplace. For more information about specific dosage forms, as well as where... Read More |
NEXT-GEN THERAPEUTICS BEGIN WITH TARGETED SEQUENCING whitepaper Mar 13, 2018 A major step towards personalized medicine was achieved in early 2014 when the first report of sequencing a human genome for $1,000 was announced—hailed by some as one of the greatest scientific and medical achievements of the last decade. Read More |
RECENT TRENDS IN PERSONALIZED MEDICINE whitepaper Mar 10, 2018 Top Country Involvement in Ongoing Oncology PGX Trials. Emerging Trend: Epigenetics. Unexpected Advantages and Potential Pitfalls of Using PGX Selection. Top Sponsors of Ongoing or Planned Oncology Trials. What's on the Horizon for Pharmacogenetics and Epigenetics in Drug Development Read More |
HIGH CAPACITY CONTAINMENT CHECK SCREENING whitepaper Mar 10, 2018 This paper will discuss the aspects of bioburden reduction in a manufacturing area or cleanroom during operational shutdown or for routine maintenance scheduling. Relevant regulatory requirements are overviewed, along with the factors constituting aseptic cleaning. What is aseptic cleaning? Asepsis ... Read More |
JAPANESE PHARMACEUTICAL MARKET whitepaper Mar 07, 2018 Pharmaceutical companies face many challenges in Japan in terms of it's complex regulatory and pricing process. Regular price cuts also pose hurdles for the introduction of new innovative drugs. Despite these challenges, the world’s second largest pharmaceutical market presents a number of... Read More |
A RECENT HISTORY OF ANTIBIOTICS AND WHERE WE MAY BE GOING whitepaper Mar 01, 2018 About Clinical Research Management, Inc. Clinical Research Management (ClinicalRM) is not only involved in the testing of new antibiotics in Phase I, II, III studies, monitoring protocol development, site selection, and assistance with FDA approvals, but is also involved in responding to the challen... Read More |
|
ORTHOGONAL AND COMPLEMENTARY NANOPARTICLE CHARACTERIZATION TECHNIQUES whitepaper Feb 26, 2018 How can I trust my data? This is a common concern for many researchers using particle measurement instrumentation. Is the data affected in any way by the measurement technology, or alternatively by the user during sample preparation or by the analysis parameters employed? To answer this question we ... Read More |
HIGH-THROUGHPUT & PHENOTYPIC SCREENING whitepaper Feb 22, 2018 Screening is an essential method for analyzing a group of chemicals, molecules, and/or compounds for a particular function in a prescribed assay. Proper screening is important for the identification of meaningful associations between compounds and targets, and screening technology has significantly ... Read More |
4 PILLARS PHARMA DISTRIBUTORS CAN STAND ON whitepaper Feb 21, 2018 Despite a recent global economic downturn, the world pharmaceutical market is currently estimated to be valued at around $300 billion and rising, according to the World Health Organization (WHO). In a recent post, the WHO states that more than a third of the market is controlled by 10 large drug com... Read More |
USING TECHNOLOGY TO REVOLUTIONIZE THE HEALTH CARE INDUSTRY whitepaper Feb 18, 2018 What if we could focus interventions on the exact group that can be most impacted? Target those that can benefit most from a particular series of actions? Identify transient patients so they could be intensely targeted before they move on? Effectively manage high-risk patients to reduce costs? This ... Read More |
|
|
TRANSFORMING CARE FOR PATIENTS AS CONSUMERS whitepaper Feb 14, 2018 Patients are increasingly behaving like consumers in a healthcare setting. As a result, they expect enhanced services and experiences when engaging with providers and health systems. How can health systems engage patients in an integrated effort that aligns with strategic goals to improve patient ou... Read More |
TRACK & TRACE IN THE PHARMACEUTICAL INDUSTRY whitepaper Feb 13, 2018 The pharmaceutical industry is not short of challenges patent cliffs, regulatory scrutiny, and R&D productivity, as well as a complex supply chain. Pharmaceutical products see several changes of hands from the manufacturers to distributors to dispensers and, finally, the patients allowing easy e... Read More |
NEURAL STEM CELLS whitepaper Feb 09, 2018 The mature mammalian central nervous system (CNS) is composed of three major differentiated cell types: neurons, astrocytes, and oligodendrocytes. Neurons transmit information through action potentials and neurotransmitters to other neurons, muscle cells or gland cells. Astrocytes and oligodendrocyt... Read More |
BEST PRACTICES IN CLOUD COMPUTING FOR HEALTHCARE whitepaper Feb 02, 2018 Healthcare providers face a variety of resource, compliance, security, cost, reimbursement, and integration challenges that have not only strained hospital IT departments but also have affected they way clinicians provide care Read More |
|
PHARMA R&D ANNUAL REVIEW 2017 whitepaper Jan 12, 2018 Welcome to Pharmaprojects’ 2017 review of trends in pharmaceutical R&D. For around a quarter of a century now, I’ve been taking an annual look at the evolution of pharma R&D, and in this article, I’ll look at how the land lies at the start of 2017. We’ll assess indust... Read More |
|
FINDING VALUE IN VOLUME - APPLICATIONS OF BIG DATA ANALYTICS whitepaper Jan 08, 2018 Learn how predictive data analytics can drive new breakthroughs, accelerate big data solutions, and derive insights from publicly available data with this eBook from The Scientist and PerkinElmer, Inc. Thanks to technology, scientific research can now generate more data than ever before. Howeve... Read More |
HEALTHCARE ANALYTICS PLATFORM: DOS DELIVERS THE 7 ESSENTIAL COMPONENTS whitepaper Jan 07, 2018 Population health, value-based care, decreasing revenues, and increasing costs are just a few of the pivotal issues challenging healthcare IT leaders today. Among other requirements, these issues call for large amounts of data, real-time data access, scalable analytics platforms, and systems interop... Read More |
MEDICAL RESEARCH LAW & POLICY REPORT whitepaper Jan 03, 2018 Will the 21st Century Cures Act further its aim to boost drug and device development in 2018? That's one of the questions the life sciences industry and attorneys are asking for the new year. The law provides extra money for research and development including ambitious research into cancer and a... Read More |
HOW LABEL VERIFICATION REDUCES PHARMACEUTICAL RECALL COSTS whitepaper Dec 21, 2017 The Drug Supply Chain Security Act (DSCSA) has been on the mind of pharmaceutical manufacturers since it was enacted in 2013, and the latest requirements are rapidly approaching. Beginning in November 2017, manufacturers will be expected to mark their products with a National Drug Code (NDC), Serial... Read More |
REFORMING BIOPHARMACEUTICAL PRICING AT HOME AND ABROAD whitepaper Nov 23, 2017 The affordability of healthcare and biopharmaceutical drugs is a top concern for Americans. It is often asserted that promoting innovation and affordable drugs are conflicting goals. New innovations, however, often provide improved health that was not previously available at any price or obviate the... Read More |
RETHINKING PHARMA FROM THE OUTSIDE IN whitepaper Nov 22, 2017 The U.S. healthcare ecosystem has faced a myriad of changes in just the last decade, and pharmaceutical companies continue to face the effects of those changes. The players have become more diverse, and today’s target audience for pharmaceuticals has expanded to include healthcare organization... Read More |
|
|
NEW INSIGHTS INTO LARGE GENOMES whitepaper Oct 18, 2017 Since Haemophilus influenzae became the first organism to have its entire genome sequenced in 19951 , there are now thousands of completed genomes covering archaea, bacteria and eukarya. However, the term ‘completed genome’ (or sometimes ‘finished genome’) is overused, as the... Read More |
ACCELERATING PRECISION MEDICINE whitepaper Oct 17, 2017 The fully realized vision of precision medicine includes the capability to rapidly diagnose, sequence and develop a personalized treatment plan based on combined analysis of genotype, phenotype, environmental, clinical and behavioral data. Precision medicine can be advanced through the “All of... Read More |
THE SCIENTIFIC PATH TO CYCLE DEVELOPMENT whitepaper Oct 17, 2017 Management of medication delivery through lyophilization - freeze-drying - is a crucial enabling process technology for many important parenteral drugs. Close to 50% of biopharmaceuticals, including enzymes, proteins and monoclonal antibodies, must be lyophilized as these therapeutic agents are insu... Read More |
THE NATIONAL PHARMACEUTICAL STRATEGY 2016 2018 whitepaper Oct 16, 2017 The Government and the Swedish Association of Local Authorities and Regions, together with a broad set of pharmaceutical actors, have agreed to continue to build on and enhance the work that has been in progress for several years under the National Pharmaceutical Strategy (NPS). There is a consensus... Read More |
LIPOSOME TECHNOLOGY whitepaper Oct 09, 2017 Polymun offers the development of liposomal formulations for all kinds of pharmaceutically active ingredients and vaccine antigens. A broad spectrum of analytical methods has been established for this purpose. Polymun produces GMP material including all necessary documentation for IMPD/IND. We also ... Read More |
DE-RISKING ANTIBIOTIC DRUG DEVELOPMENT WITH PK-PD whitepaper Oct 05, 2017 Pharmacometrics, which includes the science of pharmacokinetics-pharmacodynamics (PK-PD), is one of the most commonly misunderstood, misused, and under-appreciated resources available to drug developers. In the past PK-PD was an afterthought, but today it is required by regulators and here’s w... Read More |
LYSOSOMAL STORAGE DISORDERS whitepaper Oct 05, 2017 The aim of this hospital-based retrospective analysis is to estimate the prevalence of Lysosomal Storage Disease (LSDs) in the Eastern Province of Saudi Arabia between 1983 and 2016. A total number of 89 Saudi patients from 43 families were diagnosed with different types of LSDs within this time per... Read More |
ACCESS CONTROLS FOR MEDICAL DEVICES whitepaper Sep 27, 2017 Healthcare information technology has quickly become one of a clinician’s most powerful instruments. The implementation of technology to automate the collection and documentation of patient information, such as vital signs, continues to expand to users in more care settings within the hospital... Read More |
THE BLOCKRX PHARMA ECOSYSTEM whitepaper Sep 21, 2017 BlockRx is a series of initiatives presented by iSolve, a privately owned Blockchain solution provider for the Life Sciences Industry. The mission of BlockRx is to interconnect systems that do not readily communicate, establish data provenance that satisfies regulatory and business requirements, and... Read More |
|
|
REGULATORY COMPLIANCE IN PHARMA – SOFTWARE REQUIREMENTS AND SOLUTIONS whitepaper Sep 01, 2017 The Drug Supply Chain Security Act (DSCSA) has been on the mind of pharmaceutical manufacturers since it was enacted in 2013, and the latest requirements are rapidly approaching. Beginning in November 2017, manufacturers will be expected to mark their products with a National Drug Code (NDC), Serial... Read More |
VALUE-BASED CONTRACTING FOR ONCOLOGY DRUGS whitepaper Aug 29, 2017 A revolution is occurring in cancer treatment, based on new insights into the biology of cancer, and resulting in dozens of new drugs on the market or in the development pipeline. Many of these new drugs are “targeted” therapies that are tailored to the specific genetics and molecular pa... Read More |
AGILE PROCESS DEVELOPMENT IN BIOPHARMACEUTICALS whitepaper Aug 23, 2017 The development of novel therapeutic products involves a complex network of internal departments and external partners. Different groups across Process Development organizations typically use a variety of approaches to capture, manage, analyze and report data. These can range from paper and Excel to... Read More |
BREAST CANCER DRUGS FUNDING AND TRIALS whitepaper Aug 01, 2017 This white paper arises out of the Pink Ribbon drugs funding & trials conference, held at the faculty of pharmaceutical medicine on 23 March 2017 (full programme provided on page 13-15). The general theme to emerge from the conference is that the UK would benefit from enhanced communication betw... Read More |
AN OVERVIEW OF THE ICH-Q3D HEAVY METAL REGULATIONS whitepaper Jul 14, 2017 The presence of residual metal impurities during drug manufacturing has become a major issue in the pharmaceutical industry in recent years, prompting a wide amount of interest in solutions for their safe and efficient removal. Read More |
BIG DATA LIPIDOMICS FOR LIPID BIOMARKER IDENTIFICATION AND DRUG DISCOVERY whitepaper Jul 04, 2017 At Lipotype our expertise are lipids, lipid metabolism, lipid chemistry and lipidomics. Therefore, statistical analysis is always done with this knowledge as a basis. We treat lipids not as isolated entities but as a metabolic network with substructure and with their functions in mind. At Lipotype w... Read More |
|
SPONSOR CRO PHARMACOVIGILANCE ALLIANCES WHITE PAPER whitepaper Jun 21, 2017 Outsourcing pharmacovigilance activities is a standard business practice in a continuously expanding market segment. In the past, outsourced safety services were limited due to concerns about confidentiality, data security, and liability in cases of regulatory non-compliance, which are all still imp... Read More |
THE PHARMACEUTICAL BLOCKCHAIN OF VALUE DIGITAL TOKEN LAUNCH whitepaper Jun 20, 2017 Drug manufacturers currently do not have an effective way to securely, transparently, and rapidly track the provenance of drugs or to access the data required to combat counterfeit drug sales. (1) As a result, they are unable to decrease the time and cost it takes to bring life-saving drugs to marke... Read More |
PHARMACY AT A GLANCE whitepaper Jun 20, 2017 For the 2017 survey,the maximum sample size- the number of countries and territories with at least one FIP member organisation or candidate member organisation at the time of the survey. Read More |
|
THE FUTURE OF LIFE SCIENCES AND HEALTHCARE LOGISTICS whitepaper Jun 17, 2017 From 2015 to 2019, global healthcare spending is expected to increase by 4.3% annually. Along with growth, the sector is going through the significant transformation of its operating models and supply chains. These include three key developments: First, there are significant pressures from governmen... Read More |
PHARMACEUTICAL INNOVATION INDEX 2017 whitepaper Jun 14, 2017 The most eye-catching change in innovation for 2016 from the previous year was the fall in the number of new agents approved by the FDA, 22 for 2016 versus 41 and 45 in 2014 and 2015 respectively. Five agents being licensed at the end of 2015, plus the large number of complete response letters issue... Read More |
|
ANALYSIS OF EXTRACTABLES AND LEACHABLES whitepaper Jun 08, 2017 Manufacturers of pharmaceuticals, drug delivery systems, and biomedical devices have come under growing pressure to perform sensitive and accurate analytical studies to detect, identify, and quantify extractable and leachable compounds (E&Ls). E&Ls may be inherently toxic or may contaminate ... Read More |
2016 CLINICAL TRIALS ROUNDUP: STEADY COURSE OR CHANGING TIDES? whitepaper Jun 01, 2017 Round-up of the 2015 debuts; Distribution of phases of unapproved drug trials per therapeutic area in 2015; Top 25 disease by trial count Top locations for unapproved drug trials starting in 2015; Average number of countries disclosed per trial across most active industry sponsors Read More |
|
SOLVING COMPLEX PHARMACEUTICALS DOSING TASKS whitepaper May 18, 2017 In the field of dosing and filling in the pharmaceutical industry, one usually thinks of waterlike, non-viscous products such as solutions used for injecting. For the most part, these can be filled with a high degree of process reliability using hose pumps, rotary piston pumps and time pressure syst... Read More |
APPLICATIONS IN PHARMACEUTICAL MANUFACTURING whitepaper May 18, 2017 The use of aqueous cleaning in pharmaceutical manufacturing can provide numerous benefi ts in terms of effectiveness, minimal surface residue, and easier cleaning validation. Virtually any pharmaceutical manufacturing equipment — from tablet
presses to a stainless steel mixing tanks — can be cleane... Read More |
WHITE PAPER - CANCER MEDICINES SHORTAGES IN EUROPE whitepaper May 17, 2017 Access to medicines for cancer patients is crucial for providing high quality care. However, cancer medicines shortages are a problem affecting countries across Europe. These shortages occur when the supply of medicines, identified as essential by the health system, is insufficient to meet public he... Read More |
|
IMPROVING HOW PHYSICIANS DELIVER PATIENT CARE whitepaper May 05, 2017 This IDC White Paper, sponsored by Pure Storage, discusses important healthcare IT storage needs for the growing provider market, focusing on how all-flash storage solutions can be used to provide faster access to patient data. Patient data includes both structured and unstructured data, including h... Read More |
THE ANATOMY OF HEALTHCARE DELIVERY MODEL whitepaper Apr 04, 2017 Healthcare in the United States is and always has been a complex system. This complexity is ever increasing as value-based purchasing and population health management transform our hospital-centric industry into one focused on the continuum of care.` Read More |
|